Resistant starch supplementation helps improve metabolic, gut health

A narrative review suggests the potential of resistant starch (RS) as a dietary strategy for supporting metabolic and gut health in Asia-Pacific populations undergoing rapid nutritional transition.

At moderate-to-high doses, RS supplementation resulted in improved insulin sensitivity, hepatic lipid accumulation, and markers of gut barrier function, primarily through short-chain fatty acid (SCFA)-mediated and gut hormone pathways.

However, responses were highly context-dependent and differed based on baseline metabolic status, microbiome composition, habitual fibre intake, and RS type. Notably, metabolic and microbial shifts appeared to be greater among individuals with metabolic disturbances or low fibre intake.

“Culturally familiar RS-rich foods offer practical, regionally tailored intervention opportunities,” the investigators said.

“Standardized characterization, microbiome-stratified analyses and long-term human studies are needed to clarify who benefits most, under which conditions and through which mechanisms,” they added.

In this narrative review, the investigators collected data from animal and human studies on RS classification, food sources, microbial interactions, and metabolic regulation. They examined how responses differ by dose, RS type, baseline microbiome composition, metabolic phenotype, and habitual diet, with particular attention to traditional Asia-Pacific staple foods and ongoing dietary transitions.

“Metabolic diseases are rising across the Asia–Pacific region as traditional diets are displaced by refined, low-fibre foods,” the investigators said. “RS is a fermentable dietary component that modulates gut microbial activity and SCFA production, representing a promising strategy for metabolic and gut health.”